Veracyte, Inc.VCYTNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year net income growth rate
Latest
2052.76%
↑ 8026% above average
Average (39q)
25.26%
Historical baseline
Range
High:2052.76%
Low:-921.64%
CAGR
+14.5%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | 2052.76% |
| Q2 2025 | -113.91% |
| Q1 2025 | 37.83% |
| Q4 2024 | -66.26% |
| Q3 2024 | 164.30% |
| Q2 2024 | 407.62% |
| Q1 2024 | 93.41% |
| Q4 2023 | 4.47% |
| Q3 2023 | -252.51% |
| Q2 2023 | -3.84% |
| Q1 2023 | -110.48% |
| Q4 2022 | 55.93% |
| Q3 2022 | 8.49% |
| Q2 2022 | 34.08% |
| Q1 2022 | -37.36% |
| Q4 2021 | 25.49% |
| Q3 2021 | -56.33% |
| Q2 2021 | 78.41% |
| Q1 2021 | -420.49% |
| Q4 2020 | -95.05% |
| Q3 2020 | 62.59% |
| Q2 2020 | 5.90% |
| Q1 2020 | -57.09% |
| Q4 2019 | -921.64% |
| Q3 2019 | 70.73% |
| Q2 2019 | -30.10% |
| Q1 2019 | 38.26% |
| Q4 2018 | 30.52% |
| Q3 2018 | 28.47% |
| Q2 2018 | 31.92% |
| Q1 2018 | -8.75% |
| Q4 2017 | -19.72% |
| Q3 2017 | 3.41% |
| Q2 2017 | 11.18% |
| Q1 2017 | -86.62% |
| Q4 2016 | 21.89% |
| Q3 2016 | 49.86% |
| Q2 2016 | -11.59% |
| Q1 2016 | -25.73% |
| Q4 2015 | 10.42% |